Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Ulrik Lassen | Researchclopedia

Back to researchers

Ulrik Lassen

University of Copenhagen ORCID

557

Works

14,103

Citations

53

h-index

158

i10-index

Research Topics

Glioma Diagnosis and Treatment Lung Cancer Treatments and Mutations Cancer Genomics and Diagnostics

Affiliations

Statens Serum Institut2012–2012

Roche (Switzerland)2015–2017

University of Copenhagen1998–2026

Greater Baltimore Medical Center2008–2008

Target (United States)2007–2007

Top Works

Efficacy of Larotrectinib in <i>TRK</i> Fusion–Positive Cancers in Adults and Children

Alexander Drilon,Theodore W. Laetsch,et al.

20182,658 citations

Cancer Immunotherapy and Biomarkers

Colorectal Cancer Treatments and Studies

Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma

Henk M. Lokhorst,Torben Plesner,et al.

20151,107 citations

Actively personalized vaccination trial for newly diagnosed glioblastoma

Norbert Hilf,Sabrina Kuttruff-Coqui,et al.

2018911 citations

Preoperative Staging of Lung Cancer with Combined PET–CT

Barbara Malene Fischer,Ulrik Lassen,et al.

2009579 citations

Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial

Vivek Subbiah,Ulrik Lassen,et al.

2020501 citations

Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated <i>MGMT</i> promoter: An international randomized phase III trial

Antonio Omuro,Alba A. Brandes,et al.

2022453 citations

Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years--an analysis of 1,714 consecutive patients.

Ulrik Lassen,Kell Østerlind,et al.

1995283 citations

Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial

Vivek Subbiah,Robert J. Kreitman,et al.

2023271 citations

First-in-Class, First-in-Human Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Patients With Advanced Solid Tumors

Albiruni R. Abdul Razak,Morten Mau‐Sørensen,et al.

2016246 citations